TREM1: A Potential Therapeutic Target For Alzheimer's Disease. (Q53387554)

13 May 2018

title

TREM1: A Potential Therapeutic Target For Alzheimer's Disease. (English)

1 reference

13 May 2018

0 references

Khalil Saadipour

1

1 reference

13 May 2018

publication date

11 March 2017

1 reference

13 May 2018

published in

Neurotoxicity Research

1 reference

13 May 2018

volume

32

1 reference

13 May 2018

issue

1

1 reference

13 May 2018

page(s)

14-16

1 reference

13 May 2018

https://scigraph.springernature.com/pub.10.1007/s12640-017-9716-y

exact match

0 references

cites work

The Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E.

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9716-Y

Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9716-Y

CD33 modulates TREM2: convergence of Alzheimer loci.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9716-Y

RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9716-Y

Alternatively activated microglia and macrophages in the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9716-Y

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9716-Y

TREM1 facilitates microglial phagocytosis of amyloid beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9716-Y

Coding variants in TREM2 increase risk for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9716-Y

Variant of TREM2 Associated with the Risk of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9716-Y

Mononuclear phagocytes in the pathogenesis of neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9716-Y

The TREM receptor family and signal integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9716-Y

Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9716-Y

Glial activation in Alzheimer's disease: the role of Abeta and its associated proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9716-Y

A TREM1 variant alters the accumulation of Alzheimer-related amyloid pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9716-Y

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9716-Y

Alzheimer's disease pathologic cascades: who comes first, what drives what

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9716-Y

TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9716-Y

Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9716-Y

TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9716-Y

Clearing amyloid through the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-017-9716-Y

Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia.

21 January 2018

1 reference

12 December 2020

Fate of cerebrospinal fluid-borne amyloid beta-peptide: rapid clearance into blood and appreciable accumulation by cerebral arteries.

1 reference

12 December 2020

TREM2 is associated with the risk of Alzheimer's disease in Spanish population

1 reference

12 December 2020

Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition

1 reference

12 December 2020

A rare coding variant in TREM2 increases risk for Alzheimer's disease in Han Chinese

1 reference

12 December 2020

The role and therapeutic potential of monocytic cells in Alzheimer's disease.

1 reference

12 December 2020

TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease.

1 reference

12 December 2020

10.1007/S12640-017-9716-Y

Identifiers

DOI

1 reference

13 May 2018

PubMed ID

28285344

1 reference

13 May 2018